Desai AA - Search Results

1

A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer.

Desai AA, Innocenti F, Janisch L, DeMario M, Shepard D, Ramirez J, Fleming GF, Ratain MJ. Desai AA, et al. Cancer Chemother Pharmacol. 2004 Nov;54(5):377-84. doi: 10.1007/s00280-004-0841-y. Epub 2004 Jul 3. Cancer Chemother Pharmacol. 2004. PMID: 15235824 Clinical Trial.

2

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Desai AA, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, Vokes EE. Desai AA, et al. Cancer Chemother Pharmacol. 2005 Oct;56(4):421-6. doi: 10.1007/s00280-005-1020-5. Epub 2005 May 13. Cancer Chemother Pharmacol. 2005. PMID: 15895230 Clinical Trial.

3

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.

Yong WP, Desai AA, Innocenti F, Ramirez J, Shepard D, Kobayashi K, House L, Fleming GF, Vogelzang NJ, Schilsky RL, Ratain MJ. Yong WP, et al. Among authors: desai aa. Cancer Chemother Pharmacol. 2007 Nov;60(6):811-9. doi: 10.1007/s00280-007-0428-5. Epub 2007 Feb 17. Cancer Chemother Pharmacol. 2007. PMID: 17308893 Clinical Trial.

4

A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.

Undevia SD, Innocenti F, Ramirez J, House L, Desai AA, Skoog LA, Singh DA, Karrison T, Kindler HL, Ratain MJ. Undevia SD, et al. Among authors: desai aa. Eur J Cancer. 2008 Aug;44(12):1684-92. doi: 10.1016/j.ejca.2008.05.018. Epub 2008 Jul 21. Eur J Cancer. 2008. PMID: 18650079 Free PMC article. Clinical Trial.

5

A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors.

Desai AA, Schilsky RL, Young A, Janisch L, Stadler WM, Vogelzang NJ, Cadden S, Wright JA, Ratain MJ. Desai AA, et al. Ann Oncol. 2005 Jun;16(6):958-65. doi: 10.1093/annonc/mdi178. Epub 2005 Apr 11. Ann Oncol. 2005. PMID: 15824081 Free article. Clinical Trial.

6

A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.

Hartford CM, Desai AA, Janisch L, Karrison T, Rivera VM, Berk L, Loewy JW, Kindler H, Stadler WM, Knowles HL, Bedrosian C, Ratain MJ. Hartford CM, et al. Among authors: desai aa. Clin Cancer Res. 2009 Feb 15;15(4):1428-34. doi: 10.1158/1078-0432.CCR-08-2076. Clin Cancer Res. 2009. PMID: 19228743 Free PMC article. Clinical Trial.

7

UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990

8

Pharmacogenomics: road to anticancer therapeutics nirvana?

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Oncogene. 2003 Sep 29;22(42):6621-8. doi: 10.1038/sj.onc.1206958. Oncogene. 2003. PMID: 14528287

9

A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, Cook EH Jr, Ratain MJ. Liu W, et al. Among authors: desai aa. Cancer Res. 2005 Jan 1;65(1):46-53. Cancer Res. 2005. PMID: 15665278

10

EGFR pharmacogenomics: the story continues to mutate and evolve.

Desai AA, Ratain MJ. Desai AA, et al. Am J Pharmacogenomics. 2005;5(2):137-9. doi: 10.2165/00129785-200505020-00007. Am J Pharmacogenomics. 2005. PMID: 15813677 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters